INOFEA was founded in 2014 in Basel by a group of entrepreneurs and scientists as a spin-off from the School of Life Sciences, University of Applied Sciences and Arts, Northwestern Switzerland.

The company aims to meet a critical need related to enzyme's lack of stability and robustness: the possibility to provide enzymes with resistance to in vivo and process conditions, so that they can be fully deployed in healthcare.